Dr. Raymond Roos, Editor-in-Chief

Dr. Roos serves on the Scientific Advisory Board of Revalesio Corporation, the Data and Safety Monitoring Board for a clinical trial of a Mallinckrodt Pharmaceuticals product, has received consulting fees from M-T Pharmacy and Best Doctors, and holds shares in Amgen, Merck, Ionis, and GE.